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Abstract
Purpose: The purpose of this paper is to describe an alternative approach to telemonitoring patients suffe­
ring from Chronic Heart Failure (CHF), i.e. the Business­to­Consumer model (B2C), by extending the current 
Business­to­Business model (B2B). The B2C model is the one where the customer, in this case the patient, is 
the payer for the services consumed. We describe and perform an initial evaluation of the extension of the B2B 
to the B2C model for telemonitoring patients with CHF. 
Design/Methodology/Approach: We explored the problems in implementation of telemonitoring via the B2B 
model by means of a Root Cause Analysis, including the 5-whys method to help us understand the shortco­
mings of the B2B approach, and then the 5W1H method to explore whether the B2C is a better strategy. The 
extension of the model was executed in the Business Model Generation framework. By using qualitative con­
tent analysis techniques we supported our argumentation with findings from other studies.
Findings: The B2C model is based on the interplay of four agents – Healthcare Provider, Equipment Manufac­
turer, Payer/Regulator and Distributor/Promotor – all working together to improve health related outcomes in 
a jurisdiction. The success of the extended model in telemonitoring CHF hinges on Telemonitoring Center and 
Telehealth Nurses being repositioned in the out­of­the hospital setting. 
Social implications: We believe that penetration of mobile telehealth via the B2C model will allow for greater 
availability, access and equity in healthcare for patients with CHF.
Originality/Value: We introduced a fourth pillar to the existing B2B model, i.e. Distributors and/or Promotors. 
The B2C model we propose does not exist currently but might allow for scalability, generalizability and trans­
ferability of telemonitoring currently unattained with the B2B model.  
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Introduction
Population aging is no longer a rich­country pheno­
menon. In high­income, as well as in middle and low­
income countries the populations are getting older, the 
healthcare workforce is becoming scarce and the cost 
of care is accounting for an increasing proportion of the 
Gross Domestic Product (Bodenheimer, 2005; Lee et al., 
2010). At the same time, healthcare delivery is frag­
mented, uncoordinated and not value­based (Porter, 
2009; Gomes and Moqaddamerad, 2016). 
The greatest burden of disease globally is attributed 
to chronic diseases, which are expected to continue 
to contribute the most disability­adjusted life­years 
(DALYs) through 2020 (Krum et al., 2005). Mathers and 
Loncar (2006) further investigated the global burden of 
disease in the years 2020­2030 and found that there 
will be no change in rank from the first Global Burden of 
Disease study (Murray and Lopez, 1997), with ischemic 
heart disease topping the list of the leading causes 
of death in high­, middle­ and low­income countries 
(15.8%, 14.4% and 13.4% of total deaths, respectively). 
Ischemic heart disease is “the principal etiology of 
heart failure in the Western world” (Remme, 2000). 
Many patients suffering from chronic diseases are not 
sufficiently empowered to manage their own disease, 
they rarely have means to track the disease progres­
sion and their understanding of the disease is vague 
(Krumholz et al., 2002). Moreover, the majority of 
chronic patients are suffering from multimorbidity, 
i.e. two or more chronic diseases (Barnett et al., 2012; 
Oostrom et al., 2014; Ornstein et al., 2013). 
Telemonitoring has the potential to support timely 
detection and slower disease progression in chronic 
heart failure (Chaudhry et al., 2007). Inglis (2010) 
defined telemonitoring as “the transmission of physio­
logic data, such as an electrocardiogram (ECG), blood 
pressure, weight, respiratory rate, and other informa­
tion, such as self­care, education, lifestyle modification 
and medicine administration, using… technology like 
broadband, satellite, wireless or Bluetooth”. 
Today, telemonitoring is mostly implemented via a 
Business­to­Business model (B2B), usually involving 
cooperation between a healthcare organization and 
an equipment manufacturer (Herzlinger et al., 2014). 
A business model describes “the rationale of how an 
organization creates, delivers and captures value” 
(Osterwalder and Pigneur, 2010). The B2B model in 
electronic communication has its advantages: 24/7 
availability, breaking geographical barriers, selling in 
batches, organization­wide implementation and elimi­
nation of the ‘middleman’ (Botha et al., 2008). How­
ever, the key challenges of the current model are well 
documented too: staffing, project management, provi­
sion of support, technology, partnerships, funding and 
strategy (Joseph et al., 2011). 
It has been difficult for telemonitoring introduced via a 
B2B model to become mainstream, as it seems not to 
flourish after the pilot testing phase (Willemse et al., 
2014). A broad deployment of patient­centric solutions 
is hampered by barriers, both external, like market 
forces, and internal, like the medical technology com­
panies’ impotencies (Erhard et al., 2013). The success­
ful model of implementation will have to satisfy the 
Triple Aim criteria: 1) improve the experience of care, 2) 
improve the health of patients, and 3) reduce costs 
(Berwick et al., 2008).  
Our analysis concerns patients with chronic heart fail­
ure (CHF) because of the severity of the disease and 
its universality. Based on the Framingham Heart Study, 
30­day mortality for these patients is around 10%, 
1­year mortality is 20­30%, and 5­year mortality is 
45­60% (Levy et al., 2002). In 1928 the New York Heart 
Association (NYHA) established a chronic heart fail­
ure classification that is now used worldwide (Dolgin, 
1994), and has divided the patients into four groups 
according to the severity of the disease expressed in 
physical limitations and shortness of breath. As CHF is 
a highly lethal disease, patients need help and encou­
ragement to adhere to the medical regime (Hanyu et 
al., 1999; WHO, 2011).
Our objective is to describe a new model for the imple­
mentation of telemonitoring, i.e. the Business­to­
Consumer model (B2C), by extending the current B2B 
model. B2C model in healthcare is enabled by digital 
technologies, and the advent of internet, where the 
customer (i.e. the patient) is the payer for the services 
consumed. We are keen on exploring whether exten­
ding the B2B model to B2C can “support citizens’ and 
patients’ health and well­being in the home and on the 
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move ... and enable a virtual healthcare continuum” on 
an unprecedented scale (Schug, 2014), and if there is 
a difference to be expected in the speed and scale of 
implementation of telemonitoring for CHF patients via 
the extended business model.
Methods
Extending the Business­to­Business model (B2B) in 
telemonitoring of patients with chronic heart failure 
took three steps: 1) a Root Cause Analysis of problems 
in implementation of telemonitoring via B2B, 2) pos­
sible improvements via the B2C approach, and 3) the 
creation of the extended business model.
In the Root Cause Analysis section (Williams, 2001) we 
first applied the 5-whys method in order to understand 
the shortcomings of the B2B model in telemonitoring 
of patients with chronic heart failure, and then the 
5-whys-1-how (5W1H) method for exploring whether 
the B2C might be a better strategy. The 5-whys tech­
nique is used to explore the cause and effect relation­
ship (Asian Development Bank, 2009) while the 5W1H 
technique is used to understand the context of the 
problem, and is called the Kipling Method because 
those six questions – Who?, What?, Where?, When?, 
Why? and How? – have been immortalized in a Rudyard 
Kipling poem published in “Just So Stories” in 1902 
(Kipling, 2013). We selected and consulted scientific 
li terature, brainstormed on these questions, and took a 
devil’s advocate perspective to each of the five answers. 
The model itself was crafted according to the Business 
Model Generation framework (Osterwalder and Pigneur, 
2010; D’Souza, 2015).  We employed this methodology as 
a proven one in various companies for generating innova­
tive business models (Ahokangas and Myllykoski, 2014). 
It consists of nine building blocks: Customer Segments, 
Value Propositions, Channels, Customer Relationships, 
Revenue Streams, Key Resources, Key Activities, Key 
Partnerships, and Cost Structure.
We supported our analysis with papers published 
in peer reviewed journals, covering multiple coun­
tries, and where possible in the form of reviews and 
meta­analyses. We searched for publications in Eng­
lish, since 2000, and in some exceptional cases from 
the 1990s. In addition, we used online resources of 
business literature from the same period (including 
ideas and concepts from various consultancies, com­
panies, and magazines). As we are presenting a view­
point ar ticle, we tried to support our argumentation 
with fin dings from other authors. We opted for a con­
venience sample (Given, 2008) of papers instead of a 
more systematic selection. Convenience sampling is a 
non­probability technique that uses sources because 
of their accessibility, which introduces bias. We looked 
for papers that support and oppose our perspective and 
included both, if found. We used qualitative content 
analysis techniques for systematization of ideas from 
other authors, in order to allow for categorization and 
quantification of presented concepts (Mayring, 2000). 
We worked with prior formulated, theoretically derived 
cate gories of 5-whys and 5W1H methods, where the 
qualitative step of the analysis consisted of a methodi­
cally “controlled assignment of the category to a pas­
sage of text” (Mayring, 2000). 
Results
Root Cause Analysis
Shortcomings of the B2B approach
Here we list the barriers of the B2B model to the imple­
mentation of telemonitoring. We start from the fin­
ding that the prevailing business model is not optimal 
for telemonitoring of CHF patients (Coye et al., 2009) 
and investigate further the barriers reported in the 
literature. 
The biggest trial in telehealth to date, the Whole Sys­
tem Demonstrator (WSD), which was carried out in 
three regions in the UK, lists the following barriers to 
participation and adoption of telemonitoring: “require­
ments for technical competence and operation of equip­
ment; threats to identity, independence and self­care; 
expectations and experiences of disruption to services” 
(Sanders et al., 2012). If the business model is based 
on the telemedicine service where equipment is being 
paid for, which was the case in the WSD, the problems 
obviously relate to technical and privacy issues.
Willemse et al. (2014) list the following three barriers 
for telemedicine in Belgium: 1) financial constraints, 2) 
incomplete transmural coordination, cooperation and 
digital communication and 3) telemonitoring not being 
integrated in routine care. On the financial constraint 
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side, the authors postulate lack of equipment (devices 
were not provided after the pilot phase) and no financial 
remuneration foreseen for the follow up of telemoni­
toring. In terms of coordination, cooperation and com­
munication problems they list issues such as industrial 
partners offering different platforms for data storage; 
follow­up and coordination only performed in the own 
organization; no integration of telemonitoring data in 
patient records; transmural data sharing was not car­
ried out; regular healthcare providers often did not 
participate. In terms of integration with routine care, 
telemonitoring was considered to require an additional 
effort in the pilot projects (Willemse et al., 2014).
Coye et al. (2009) examined in greater depth the over­
view of barriers to the implementation of remote patient 
telemonitoring. On financial constraints they state that 
“financial models and assumptions needed to calculate 
costs and return on investment do not exist” (p. 129). 
Without detailed calculations of direct and indirect costs, 
be it healthcare or non­healthcare, no sustainable inno­
vation can be successfully introduced. They continue: 
“perhaps most difficult of all – there are few models of 
implementation by individual physicians, large medical 
groups, or healthcare delivery systems to draw upon” 
(Coye et al., 2009). Continuing to ask why? will even­
tually lead us to the “principal barriers” to innovation 
in chronic care: the (poor) effects of benefit design and 
reimbursement mechanisms (Baron and Cassel, 2008; 
Bodenheimer, 2008; Boult et al. ,1999). 
Medicare/Medicaid, a US national social insurance, 
“reimburses for telehealth services when the origina­
ting site (where the patient is) is in a Health Profes­
sional Shortage Area (HPSA) or in a county that is 
outside of any Metropolitan Statistical Area (MSA), 
defined by HRSA and the Census Bureau, respectively” 
(HRSA, 2015). Medicare will reimburse for face­to­
face interactions, store­and­forward applications (e.g. 
remote ECG application) but there is no single accepted 
reimbursement standard for private payers. The Ame­
rican Telemedicine Association conducted a national 
online survey of private payer reimbursement in 2012 
and found “that private payers have administrative 
rules regarding telehealth reimbursement that are bar­
riers to services and reimbursement, and that some 
providers would benefit from being better informed 
about billing and coding for telehealth services and how 
to advocate for telehealth services reimbursement” 
(Antoniotti et al., 2014). In conclusion, Antoniotti et al. 
(2014) list the major reasons for not billing for services 
delivered via telemedicine: no Medicaid reimbursement 
(33%), major payers do not pay (32.4%), practice in 
urban area (19.3%), services are bundled through con­
tracts (17.4%), could not get support from my organiza­
tion (4.7%), too risky for penalties for fraud and abuse 
(4.7%), and other (43.9%).
Improvements via the B2C approach
Extending the B2B model towards the B2C model con­
cerns the improvements in the following aspects: cost­
effectiveness (i.e. health for money), modus and timing 
of introduction, education and self­management. 
One of the impediments to wider uptake of tele­
monitoring is its business model (Acheampong and 
Vimarlund, 2014) while the other is its cost­effective­
ness (Grustam et al., 2014). The evidence that tele­
monitoring saves costs while improving outcomes is 
still debated in the literature (Blum and Gottlieb, 2014; 
Klersy et al., 2011; Upatising et al., 2015), while the opti­
mal business model is yet to be found. Telemonito­
ring is currently introduced via the not easily scalable 
B2B approach, and literature does not examine other 
modalities of implementation or their cost­effective­
ness (Acheampong and Vimarlund, 2014; Dijkstra et al., 
2006; Griffioen, 2012). Addressing the cost­effective­
ness barriers as well as market and consumer barriers 
(regulations, ease of use, technology, access and cove­
rage, promotion etc.) can lead to scalability.
Telemonitoring of chronic/multimorbid patients today 
is a time­bound activity. Patients usually stay with 
the B2B telemonitoring service anywhere from one to 
eighteen months (Maric et al., 2009), whereas they 
could continue to use the B2C model for the duration of 
the disease (i.e. lifetime, as they are paying for the ser­
vice themselves). An inability to properly manage CHF 
usually lands those patients in the emergency room 
(ER) and this significantly shortens their life pros­
pects (Sanghavi et al., 2014). Having access to the tele­
monitoring service at all times can be highly beneficial 
to CHF patients as telemonitoring has been shown to 
reduce mortality, hospital readmission and bed occu­
pancy, even at short intervention and follow­up inter­
vals (Louis et al., 2003).
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CHF patients should ideally be approached after an 
adverse health event (e.g. heart failure, mild infarct, 
stroke). That is a time when patients are most aware 
of their health problems and need to actively partici­
pate in the hospital discharge process (Hesselink et al., 
2014). Currently patients are recruited to clinical stu­
dies involving B2B telemedicine systems months after 
the onset of the disease. In the B2C model patients can 
be informed about the existence of the service at the 
point of departure from the healthcare system, or via 
public health channels (e.g. mass media campaigns). 
The B2C telemonitoring service should be available at 
all times to patients in a given jurisdiction.
Patient education is of importance to guarantee adhe­
rence. The self­management component of CHF pro­
grams (physical activity, drug adherence, diet, etc.) has 
“a positive effect, although not always significant, on 
reduction of numbers of all­cause hospital readmit­
ted patients … decrease in mortality and increasing 
quality of life” (Ditewig et al., 2010). The educational 
component of the system allows for empowerment 
of patients, while the monitoring component helps 
with early detection of disease worsening. In most B2B 
cases the education is offered by a nurse – in person or 
via the telephone and rarely via the device (Maric et al., 
2009). This prevents patients from revisiting the mes­
sage and impedes learning. In the B2C model education 
is always at hand, which should promote learning and 
behavioral change.
One of the main problems in telemonitoring is scal­
ability (Zhang et al., 2014), which comes with regula­
tory issues. The European Commission has indicated 
in the e­Commerce Directive that “for business­to­
business (professional­to­professional) telemedicine 
services,  such as teleradiology, the country of origin 
principle applies: the service offered by the profes­
sional must comply with the rules of the Member State 
of establishment. In the case of business­to­consumer 
activities (which might be relevant to telemonitoring 
services) the contractual obligations are exempted 
from the country of origin principle: the service might 
need to comply with the rules of the recipient’s coun­
try” (Commission of the European Communities, 
2008). This indicates that the telemonitoring provider 
should be based in the EU jurisdiction most favorable 
to eHealth and provide services to other member states 
via the internal market clause (Vollebregt, 2012). Using 
mass media to reach consumers, combined with refer­
rals by physicians and pharmacists, might be a way to 
enroll patients in their thousands without establishing 
a physical presence in the jurisdiction (as is necessary 
with B2B today). Thus Business­to­Consumer (B2C) 
telemonitoring might pave the way to population­wide 
health monitoring either within or between countries.
The B2C telemonitoring service can be introduced ini­
tially as an increment of the B2B model. The B2B model 
is currently used by technology providers to implement 
their products in high­income countries. In the US, for 
example, after the adoption of the “meaningful use 
of IT in healthcare” initiative, Congress invested bil­
lions of dollars in infrastructure building to support 
three goals: improve quality of care, reduce costs, and 
increase access and coverage (Buntin et al., 2010). Pre­
vious investments in B2B telemonitoring can help with 
the transition to B2C as systems have been deployed 
already, and the research findings are available too 
(Weinstein et al., 2014). The rapid evolution of mobile 
health apps will be the promotor of B2C telemonitoring 
and will encourage patients to “accept greater respon­
sibility for their own healthcare either individually or 
with their healthcare navigators” (Dorsey et al., 2013; 
Weinstein et al., 2014, p. 185). 
Paré et al. (2007) found out that: “home telemoni­
toring of chronic diseases seems to be a promising 
patient management approach that produces accurate 
and reliable data, empowers patients, influences their 
attitudes and behaviors, and potentially improves 
their medical conditions” (p. 274). However, there is 
inconclusive evidence of the clinical effectiveness and 
cost­effectiveness of telemonitoring for CHF patients 
(Clark et al., 2007; Grustam et al., 2014; Wootton, 
2012). While business model and cost­effectiveness 
are considered to be major barriers to further imple­
mentation of telemonitoring in chronic disease mana­
gement, the enablers are to be found in duration of 
the intervention, modus and timing of introduction, 
education, and self­management (Table 1). Extending 
the B2B model towards B2C might be a way to tackle 
all those major deficiencies in the telemonitoring ser­
vice today. 
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B2B Barriers B2C Enablers
1)  Technical - requirements for 
technical competence and 
operation of equipment, 
2)  Personal - threats to identity, 
independence and self-care, 
3)  Organizational - incomplete 
transmural coordination, 
cooperation and digital 
communication, and
4)  Financial - poor effects of 
benefit design and reim-
bursement mechanisms.
1)  Effectiveness – addressing 
regulations, ease of use, 
technology, access and  
coverage, promotion, etc. can 
lead to scalability,
2) Modus and timing - the  
service is  available at all 
times, for a lifetime,
3) Education - always at hand, 
which should promote lear-
ning and behavioral change, 
4)  Self-management - better 
health outcomes.
Table 1: Summary table of the barriers and enablers in  
CHF telemonitoring
Business Model Generation
Next, we describe in detail the Business­to­Con­
sumer (B2C) model. We believe that its success 
hinges on two entities – the Telemonitoring center 
and Telehealth nurses – being repositioned in the 
out­of­the hospital setting. We depict the position 
of the two in the Business Model Canvas (Anon, 
2014a). The canvas allows for improved clarity and 
understanding of this value proposition. Figure 1 
presents the extended business model based on the 
findings generated by the 2 preceding steps ­ a Root 
Cause Analysis of problems in implementation of 
telemonitoring via B2B, and possible improvements 
via the B2C approach.
Key Partners
MONITORING & WELLNESS
1) Strategic alliance between 
payer/regulator and distribu-
tor/promotor,  
2) Cooperation between 
healthcare provider and 
equipment manufacturer,  
3) Joint venture between 
equipment manufacturer 
and distributor/promotor, 
and  
4) Buyer-supplier relationship 
between insurer/regulator 
and healthcare provider
Key Activities
MONITORING 
1) Production – Creating the 
mobile app.    
2) Problem solving – Care 
coordination and bidirec-
tional communication, and  
3) Platform/Network - 24/7 
unobtrusive telemonitoring
WELLNESS
1) Production – Creating the 
mobile app,    
2) Problem solving – Well-
ness tracking and support
Value Propositions
MONITORING
24/7 unobtrusive personal-
ized telemonitoring (disease 
monitoring, education, seri-
ous games and communi-
ties) with biweekly calls from 
a personal care coordinator 
(telehealth nurse) 
WELLNESS 
Wellness tracking (disease 
tracking, education, serious 
games and communities)
Customer Relationships
MONITORING
1) Dedicated personal assis-
tance, 
2) Automated alerts and 
messages, and  
3) Communities
WELLNESS
1) Automated alerts and 
messages, and  
2) Communities
Customer Segments
MONITORING
1) CHF patient after an 
adverse event,  
2) Tech savvy with smart-
phone and mobile internet, 
and  
3) Able to pay for the service
WELLNESS
1) Older than 55 years and at 
cardiovascular risk,  
2) Tech savvy with smart-
phone and mobile internet, 
and  
3) Able to use the service
Key Resources
MONITORING
1) Physical - Telemonitoring 
center,  
2) Financial - initial invest-
ment in the venture,  
3) Intellectual - IP and algo-
rithms, and 
4) Human - Telehealth nurses
WELLNESS
1) Physical - Telemonitoring 
center,  
2) Financial - initial invest-
ment in the venture,  
3) Intellectual - IP and 
algorithms
Channels
MONITORING & WELLNESS
1) Distribution of the app/
service via the established 
app stores,  
2) Communication with 
patients via telecom 
operators
Cost Structure 
MONITORING
1) Telemonitoring equipment
2) Telecommunication charges
3) Salaries
4) Overhead
WELLNESS
1) Backend charges
2) Telecommunication charges
Revenue Stream(s)
MONITORING
Subscription based (premium model)
WELLNESS
Free (freemium model)
Adapted from Business Model Generation (Osterwalder & Pigneur, 2010)
Figure 1: The B2C model of telemonitoring CHF expressed in the Business Model Canvas
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Customer Segments
At the very beginning of the business model generation, 
we need to understand for whom is the value created, 
to: Mass Market, Niche Market, Segmented, Diversified 
or Multi­sided Platform (Osterwalder and Pigneur, 2010). 
Cambridge University Press (2015) explains that “Pro­
duct … designed for the mass market is intended to be 
bought by as many people as possible, not just by peo­
ple with a lot of money or a special interest”, and Market 
segment is defined as “a group of possible customers 
who are similar in their needs, age, education, etc.”. This 
model concerns CHF patients, as CHF contributes the 
most to mortality from chronic diseases in the world 
(WHO, 2011), making this a segmented market.
The newly crafted business model caters for the specific 
customer segment, i.e. CHF patients with a certain seve­
rity of the disease expressed in the New York Heart Asso­
ciation (NYHA) framework (Dolgin, 1994). It is too early 
to say which class of patients – NYHA class I to IV – can 
benefit the most from B2C telemonitoring, or whether it 
is a cost­effective intervention. For the time­being we 
will consider all NYHA class patients as possible custo­
mers. The criteria for the customer are: 1) CHF patient 
after an adverse event such as a heart attack or stroke for 
the monitoring track, and/or older than 55 years for the 
wellness track, 2) tech savvy with smartphone and mobile 
internet, and 3) able to pay for the service. In the US 17% 
of the daily mobile internet users older than 55 years pur­
chased a service or a product via smartphone, and have 
on average 5.7 paid apps on their devices (Google, 2013). 
Thus the value proposition, distribution channels, and 
customer relationships need to be tailored to the specific 
requirements of this customer segment.
Value Proposition(s)
A Value Proposition “creates value for a Customer Seg­
ment through a distinct mix of elements catering to that 
segment’s needs” (Osterwalder and Pigneur, 2010). The 
same authors define values as quantitative (e.g. price, 
speed of service) and qualitative (e.g. design, customer 
experience). What value can be delivered to the identi­
fied customers via the B2C model? Several, from the 
following categories: Newness, Performance, Customi­
zation, Getting the Job Done, Design, Brand/Status, Cost 
Reduction, Risk Reduction, Accessibility and Conveni­
ence/Usability (Osterwalder and Pigneur, 2010). 
The key success factors, in terms of customer needs 
– effectiveness, costs, accessibility, ease of use, cre­
dibility – correspond to the value­added characteris­
tics of the B2C model. The duration of intervention, 
the modus and time of introduction, education and 
self­management, the effectiveness in terms of better 
healthcare outcomes, are all important improvement 
points for B2B, and at the same time value proposi­
tions for B2C telemonitoring. The B2C value proposi­
tion is inspired by Triple Aim (Berwick et al., 2008) and 
specified for telemonitoring of patients with CHF from 
a consumer’s perspective. As such, the key success fac­
tors of the B2C model address different aims: Care (e.g. 
accessibility, ease of use, credibility), Health, and Costs 
(e.g. cost reduction, effectiveness, scalability).  
An example of the B2C telemonitoring service that 
we will use in this business model generation exer­
cise concerns: 1) a 24/7 unobtrusive personalized tele­
monitoring service (monitoring, education, games, and 
communities) with biweekly calls from personal care 
coordination, or for a wider audience of 55+ years, 2) 
a wellness tracking app (disease tracking, education, 
games, and communities). Personalized monitoring 
entails algorithm pushing nudges, content, education, 
and scripted interactions to the patient according to 
the signal reads from the monitoring devices. Personal 
care coordinator is a dedicated telenurse that monitors 
the patient via a dashboard, and acts as the “health 
coach” (supports the patients throughout their patient 
journey). The personalization on the patient side is 
driven by the severity of the disease , therapy adhe­
rence, willingness to pay, motivation, etc. 
In the event of an emergency, or during the night when 
the patient is not supervised by a real person, the clever 
algorithm flags the situation and logs an automatic 
call with an emergency service on behalf of the patient 
(Leijdekkers and Gay, 2008). The telemonitoring ser­
vice should not be mistaken for an emergency service.
Currently, telemonitoring can be provided via several 
platforms (e.g. smart and mobile devices, TV, tele­
phone) but is executed in a one-size-fits-all fashion. 
Each patient is unique, and the customization of the 
service is a crucial part of the value proposition in the 
B2C approach. This can be done via smart algorithms 
using educational content, surveys, information 
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provision, games, etc. – all personal and engaging. 
Patients a are happy when care is tailored to them per­
sonally and/or to their individual needs (Minvielle et al., 
2014). 
The brand power is crucial to service uptake. Aaker 
(1991) provided a framework for assessing brand equity 
with four dimensions: brand’s perceived quality, brand 
awareness, brand associations, and brand loyalty. 
Patients might not be comfortable with IT companies 
monitoring their health, nor allow “one’s biometric indi­
cators [to] be constantly measured, analyzed and dis­
played publicly on Facebook or Twitter” (Lupton, 2012), 
but the recently introduced ResearchKit from Apple 
proves that things are beginning to change – smart­
phones will track one’s health status, and even one’s 
genetic information – and thousands of people have 
signed up for this already (Regalado, 2015). An estab­
lished player in the healthcare domain with a strong 
brand has a fair shot at monitoring wider populations. 
In this way, the adoption of a new technology can be 
accelerated (Jin and Li, 2012).
B2C value proposition features cost reduction, risk 
reduction, accessibility and convenience/usability. 
It has a similar proposition to B2B, where customers 
essentially buy “peace of mind”, but with more con­
venience as the service runs on a personal device and is 
considered “device­agnostic”. It also reduces costs for 
the customer, as there is no need to install the equip­
ment or to run updates. There is no “downtime risk” 
as the service is hosted in the cloud – the top 10 cloud 
services have downtime of less than 99.86% (Gagnaire 
et al., 2012). Convenience is assured by unobtrusive 
telemonitoring, via third party devices, and seamless 
connection via a backend, over mobile internet. This 
value proposition allows accessibility to a first­class 
healthcare service, which is assured even in the areas 
where such medical service was previously unheard 
of. According to the International Telecommunication 
Union (2014) there are almost 3 billion internet users, 
two­thirds of them in the developing world, and the 
number of mobile­broadband subscriptions reached 
2.3 billion globally. Smartphones and mobile internet 
are prerequisites for enjoying 24/7 coverage and medi­
cal service via the B2C telemonitoring model. With 
accessibility comes scalability, a necessary but not suf­
ficient condition.
Channels
Channels are crucial in reaching a designated Customer 
Segment. Osterwalder and Pigneur (2010) distinguish 
between direct channels (e.g. sales force, web sales) and 
indirect channels (e.g. own stores, partner stores, whole­
saler), as well as between owned channels and partner 
channels. Finding the right mix is important for success­
fully bringing the value proposition to the market. 
The focus of the B2C model lies on locking­in the cus­
tomers with a superb value proposition, by establishing 
a relationship with the personal health coach (i.e. tel­
ehealth nurse) rather than on owning the channels for 
marketing or distribution. The B2C model in telemoni­
toring should rely on distribution of the app/service via 
the established (app)stores, while the communication 
with patients should be executed in a secure and con­
trolled manner via telecom operators (Deutsche Tele­
kom, 2015; Frost & Sullivan, 2015). 
This is a departure from the historical channel for 
telemonitoring, i.e. hospitals. Several factors that 
hamper wider deployment of telemonitoring if exe­
cuted within the hospital setting, i.e. lack of funding, 
motivation and cooperation between the hospital and 
the GP (Willemse et al., 2014), can be eradicated by new 
ways of healthcare delivery. B2C utilizes new channels 
and customer relationships in order to raise awareness 
of and extend the reach of telemonitoring.
Customer Relationships
Osterwalder and Pigneur (2010) distinguish between 
several categories of Customer Relationships, which 
may coexist in a provider’s relationship with a particu­
lar Customer Segment: Personal Assistance, Dedicated 
Personal Assistance, Self­service, Automated Services, 
Communities, and/or Co­creation.
CHF patients can establish three types of relationships 
via the B2C model: dedicated, automated and com­
munity­based, depending on the choice of the service 
model, premium monitoring service or freemium well­
ness service.
Patients who pay, or are sponsored to enroll in the 
telemonitoring service, can receive dedicated personal 
assistance from a telehealth nurse (i.e. bimonthly calls 
and check­ups). Suter et al. (2011) find that “during 
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... assessment calls, telehealth nurses often provide 
education regarding cause and effect relationships 
between personal health behaviors and obtained 
physiological results, serving to reinforce prior teaching 
regarding disease self­monitoring and self­manage­
ment” (p. 87),  thus unequivocally supporting the cru­
cial role played by telehealth nurses in telemonitoring. 
Patients/customers who download the app for free, 
and are on the wellness track can have automated ser­
vices (e.g. education, games, and reminders). Both seg­
ments should enjoy communities, i.e. online forums for 
exchange of experiences and information in a similar 
fashion to PatientsLikeMe (Wicks et al., 2010). 
Revenue Streams
Revenue Streams represent the cash a company gene­
rates for each Customer Segment (Osterwalder and 
Pigneur, 2010). We believe that the strongest moti­
vation for patients with chronic diseases, the value 
proposition one is willing to pay for, is “peace of mind” – 
knowing that someone is looking after you at all times. 
Bradford et al. (2005) investigated the willingness to 
pay for telemedicine and found that 30­50% of hyper­
tensive patients are willing to pay at least $20 per 
month, while for the CHF patient this number was 
even higher. Qureshi et al. (2006) found that “the 
majority of those choosing telemedicine (95%) were 
also willing to pay a median of $25 (5 to 500 dollars) 
out of pocket”, while Seto (2008) found that 55% of 
heart failure patients were willing to pay $20, and 19% 
were willing to pay $40. In a more recent poll of 2019 
customers, the result showed that the majority (62%) 
thinks that a telehealth visit should cost less than an 
in­person visit, which currently costs $82 for first­time 
patients (American Well, 2015). These payments can 
be a part of two different types of revenue streams: 
transactional revenues, i.e. one­off payments, and/or 
recurring revenues.
The B2C approach for telemonitoring chronic diseases 
revolves around subscription. The app/service can 
be free for the wellness track (freemium service with 
vi deos, education, and tracking of disease progression) 
and subscription based for the monitoring track (pre­
mium service consisting of telemonitoring, coaching, 
contact with telehealth nurses, and coordination of 
care). 
Key Resources
Resources allow an enterprise to create and offer a 
value proposition, reach markets, maintain relation­
ships with customer segments, and earn revenues 
(Osterwalder and Pigneur, 2010). Key resources in this 
venture are physical (telemonitoring center), finan­
cial (initial investment in the venture), intellectual (IP 
and algorithms) and human (telehealth nurses). We 
will explore the crucial two, without which it would be 
impossible to extend the B2B model towards B2C. Tele­
health centers are a new organization of healthcare ser­
vices for the digital age, ready to handle the complexity 
of the care­coordination process in tele monitoring, 
while telehealth nurses are specially trained providers 
of those services. 
Telehealth Nurses
Telehealth nurses are seen as “health­quarterbacks” in 
charge of organizing and implementing care protocols 
for chronic/multimorbid patients (Monroe, 2014). Their 
role is in care­coordination between the patient, the 
physician, the pharmacist, and the informal caregiver. 
It should be noted that a proper relationship between 
the patient and the telehealth nurse should be estab­
lished and maintained, to prevent confusion for the 
patient about who is in charge of their wellbeing in the 
complexity of healthcare (Span, 2015). Effective chronic 
care management is based on interaction between the 
healthcare professionals and the patient’s social sup­
port network (Klasnja and Pratt, 2012). The patient 
allows and introduces one or more informal caregivers 
into the care­coordination chain, while the telehealth 
nurse manages the stakeholders. This is all possible 
with the current state of technology. 
The telehealth nurse provides a personalized care to 
patients enrolled in the telemonitoring service. On ave­
rage, he/she contacts the patient every two weeks, for 
a 10­minute check­up. This is adequate time for a quick 
conversation, as patients usually get only 10­15 minutes 
with their physician once every three months (Kaplan et 
al., 1995; Oxtoby, 2010). This allows one nurse to moni­
tor and communicate with approximately 50 patients 
a day, or a maximum of 500 patients per month (with 
one monthly contact one nurse would be able to monitor 
almost 1000 patients). This is somewhat similar to the 
existing telemonitoring service in Hull, UK, where one 
telemonitoring nurse oversees 200­400 CHF patients 
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(Anon, 2014b). Telehealth nurses could be trained in 
order to reach the efficiency level needed to maintain 
the cost­effectiveness of the B2C model.
Telemonitoring Center
The B2C model introduces another entity to healthcare – 
a telemonitoring center – in order to provide 24/7 digital 
monitoring on smartphones (or a mobile device of the 
user’s choice). The telemonitoring center is a physical 
entity that hosts telehealth nurses and the equipment, 
and performs two functions: telemonitoring and com­
munication with patients. The monitoring part is auto­
matic/algorithmic and runs in the background, while 
the communication between the telehealth nurse, the 
patient and the care team occurs during working hours. 
The monitoring service proposed here should persona­
lize the experience for each patient. For patients that 
have an older set of measuring devices (e.g. weight 
scale, blood pressure cuff, ECG recorder, pulse oxime­
ter) the measurements should be entered into the app 
manually. This is usually tedious and error prone, but 
with the new automated equipment that connects 
via telephone or internet the transfer of the mea­
surements is automatic and unobtrusive (Chaudhry et 
al., 2007). The B2C model is device­agnostic as not to 
restrict the telemonitoring service to device manufac­
turer silos, and because peripheral measuring devices 
might soon be commoditized (c.f., Iivari et al., 2016). 
The communication system can be built on top of va rious 
unifying communication platforms, which allow for 
video calls, voice calls, instant messaging and presence 
(Winters and Hanna, 2012). This can be supplemented 
with email and an SMS/MMS service for sending pic­
tures and educational materials. The Health Insurance 
Portability and Accountability Act of 1996 (US) demands 
that telemonitoring networks take precautions in order 
to prevent third parties from intercepting health­related 
data (Pecina et al., 2011). There are many existing sys­
tems which are HIPAA compliant (i.e. full support of 
privacy issues) and can be readily deployed around the 
globe to ensure secure communication with patients.
Key Activities
Key Activities are required in order to create and offer a 
Value Proposition, to reach markets, maintain Customer 
Relationships, and earn revenues (Osterwalder and 
Pigneur, 2010). Key Activities can be categorized into: 
Production, Problem solving and Platform/Network. 
The monitoring service can reuse the design, algo­
rithms and functions of the established B2B tele­
monitoring platforms (i.e. physical systems) but adapt 
them to the B2C context (i.e. cloud services), in order 
to achieve scale and reach. This represents a departure 
from a product­oriented to a service­oriented approach. 
By introducing electronic distributors/promotors into 
healthcare delivery, the problem of population­wide 
healthcare coverage for chronic/multimorbid patients 
can be solved at regional, community, and individual 
levels (Kahn et al., 2010). Recently one of the major 
insurers in the US, UnitedHealth, widened telehealth 
coverage to millions of Americans, finally removing one 
of the last obstacles to scale (Forbes, 2015).
Evolving the B2B model to seize this opportunity 
means introducing a new “platform” into healthcare 
(i.e. the telemonitoring center) that performs key 
activities: 24/7 unobtrusive telemonitoring of patients 
with chronic diseases (CHF in this case), bidirectional 
communication with patients, and care coordination by 
telehealth nurses. 
Key Partnerships
The Key Partnerships describe the network of sup­
pliers and partners that make the business model 
work (Osterwalder and Pigneur, 2010). In order to take 
telemonitoring out of the hospital setting and into the 
telemonitoring center where customers can purchase 
a telemonitoring solution on their own, there needs to 
be governance and awareness, in addition to providers 
of healthcare and equipment manufacturers (Figure 2).
Governments aim to improve the performance of their 
healthcare systems (Smith et al., 2001) and rely on 
hospitals and national licensing authorities to provide 
services and to regulate the healthcare market. Out of 
58 counties in the world that currently have Universal 
Healthcare Coverage (Stuckler et al., 2010) there are 
developed countries where the government is the payer 
and the regulator (e.g. Canada where the government 
pays for 70% of healthcare expenses) and countries 
where these roles are separated (e.g. the Netherlands). 
Governance, consisting of payers and regulators, is one 
of the four pillars that “hold” the B2C model. 
Journal of Business Models (2018), Vol. 6, No. 3, pp. 106-129
116
People are usually made aware of the existence and 
availability of the telemonitoring service by physicians 
or public health authorities, but here we are advocat­
ing a new route – informing customers directly via mass 
media. Targeted mass media campaigns are often used 
to inform patients about specific health issues or to pro­
mote desired behavior – for instance, to increase the 
uptake of screening, vaccination or healthy nutrition 
(Coulter and Ellins, 2007), but rarely to inform these peo­
ple about the availability of certain healthcare services in 
a jurisdiction. The extension of the B2B model towards 
B2C mainly involves the introduction of mass media, as 
a new type of channel for delivering healthcare services. 
Media, consisting of distributors and promotors, repre­
sents another important pillar of the B2C model.
Regarding partenrships, the new business model can 
create the strategic alliance between non­competitors 
– payer/regulator and distributor/promotor – working 
together to raise awareness and improve the manage­
ment of chronic diseases in their jurisdiction. It also can 
create a buyer­supplier relationship between healthcare 
provider and payer/regulator, as public bodies might 
want to procure telemonitoring for certain groups of 
citizens. On the other end, a joint venture between 
equipment manufacturer and distributor/promotor can 
be expected as the B2C model relies heavily on infor­
ming the customers/patients about the availability 
of the service in their jurisdiction. Finally, cooperation 
– a strategic partnership between competitors – can 
be established between equipment manufacturer and 
healthcare provider as they both compete for the same 
customer/patient in the B2C model. 
With the introduction of the B2C model for telemoni­
toring chronic or multimorbid patients a new way of 
delivering healthcare services will be achieved. Chronic 
patients will be “shared” between home telemonito­
ring (remote management) and traditional in­hospital 
services, while today Accountable Care Organizations 
are trying to introduce nurse telephone support and 
tele monitoring in an attempt to avoid readmission 
penalties (Burke et al., 2013). This will take place as a 
symbiosis between the four sectors: healthcare, indus­
try, government and media. Figure 2 depicts the four 
building­blocks of the B2C model and their relationship 
Figure 2: Key partnerships in B2C telemonitoring of patients with chronic diseases in a healthcare sys-
tem where government is the payer and the regulator
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with one another in a healthcare system where the 
payer and the regulator are the same body, i.e. the 
government. 
Cost Structure
Costing is particularly important in delivering this value 
proposition to chronic or multimorbid patients. Creating 
and delivering value, maintaining customer relation­
ships, and generating revenue all incur costs (Oster­
walder and Pigneur, 2010). The costs can be fixed or 
variable, and the business can be cost­driven or value­
driven. We believe B2C telemonitoring is value driven 
because it focuses on value creation for chronic or mul­
timorbid patients, i.e. 24/7 unobtrusive monitoring, 
peace of mind, coordination of care, creation of com­
munities, education, and help with self­management. 
Discussion
The extension of the B2B business model into the B2C 
model for telemonitoring CHF presented here proposes 
a synergy between equipment manufacturers, health­
care providers, payers and regulators, distributors and 
promotors in order to achieve population­wide telemoni­
toring. It calls for the establishment of a telemonitoring 
center in an out­of­hospital setting, staffed by telehealth 
nurses, for reasons of effectiveness and efficacy. In this 
way telemonitoring can enable care to be provided in vari­
ous settings (e.g. home, work, on the move), instead of 
ha ving patients seek care in hospitals and care organiza­
tions. The B2C model connects the business side with the 
consumer side of telemedicine, as shown in Figure 2. It is 
our belief that extending the B2B model toward the B2C 
will increase the speed and scale of adoption of this tech­
nology in chronic disease management.
We presented our analysis in the Business Model Can­
vas by Osterwalder and Pigneur (2010) because of 
the methodological strength it embodies – a media­
tion between the idea and the customer (Coes, 2014). 
The advantage of the Canvas is in recognizing the key 
importance of the value proposition to the end cus­
tomer of the B2C model – the patient. The limitation is 
in absence of a strategy portrait, and the relationship 
of the business model with a possible strategy. Teece 
(2010) theorized that the two are connected, where 
strategy follows business modelling. Thus, we tried to 
present possible strategic partnerships in Figure 2. 
Coye et al. (2009) compiled an overview of the early 
business models for chronic disease management, 
finding that “all of the previous operations” were B2B 
and have proven unsuccessful in bringing telemonitor­
ing to the masses. In these organizations the patients, 
i.e. the consumers, were not able to procure the ser­
vice on their own. Evidently, in the beginning scalabi­
lity, generalizability and transferability were trumped 
by implementation problems.
As with most products and services in healthcare, the 
B2B model is designed with a primary focus on provi­
ders. However, the B2C model breaks away from the 
traditional consideration of providers as key buyers and 
shifts the attention to patients themselves, recogni­
zing their vital need for convenience, accessibility, and 
customized education. The B2C model capitalizes on 
the proliferation of smartphone devices, tablets and 
the rapid rise of the internet, and offers the solutions 
directly to patients, while breaking down the barriers 
created by intermediate functions.
The B2C model bears similarities to the Blue Ocean 
Strategy approach. Challenging an industry’s conven­
tional wisdom about which buyer group to target can 
lead to value innovation – i.e. the creation of innova­
tive value to unlock new demand (Kim and Mauborgne, 
2005). According to Kim and Mauborgne (2005) one 
approach to create a new uncontested market and sat­
isfy demand from a previously overlooked set of bu yers 
is to look across buyer groups. Since the B2C model 
shifts the perception in terms of the primary buyer 
group from providers to patients, and offers the latter 
group additional critical products/service attributes 
that unlock value, it bears many similarities to a blue 
ocean strategy. 
However, the concept of value is not without problem in 
healthcare. Welfare economists still follow an influential 
concept by Hersany (1982, p. 55) that “in deciding what 
is good and what is bad for a given individual, the ulti­
mate criterion can only be his own wants and his own 
prefe rences.” In healthcare value is not expressed only 
as a personal preference for an outcome, but more typi­
cally as a “triple aim” (Berwick et al., 2008): health gain, 
improving patient’s satisfaction with care, and/or redu­
cing per capita cost of care. The B2C model would most 
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likely not improve health, but deliver on other two types 
of value. 
The B2C approach might also solve the transferability 
and generalizability issues in telemonitoring, explored 
in the Model for Assessment of Telemedicine (Kidholm 
et al., 2010), by controlling for differences in demogra­
phy and disease (telemonitoring works in the same way 
for different age and disease­severity groups), avail­
ability of healthcare resources (telemonitoring is avail­
able in a whole jurisdiction, irrespective of geography), 
variation in clinical practice (telemonitoring introduces 
the same standards of care), alignment of incentives to 
healthcare professionals and institutions (telemonito­
ring centers are outside the hospital setting), unifor­
mity of costs and prices (the fee for a telemonitoring 
service is the same for everyone). 
Three key characteristics of a good business model 
are alignment, self­reinforcement, and robustness 
(Casadesus­Masanell and Ricart, 2011). The B2C model in 
telemonitoring of patients with CHF is aligned with the 
goals of all four stakeholders and represents a middle 
ground between the business needs and the consumer 
needs. It is self­reinforcing because allowing patients to 
procure a telemonitoring service at their own request 
will help achieve the “triple aim” in healthcare (Berwick 
et al., 2008) by improving the patient’s experience of 
care, improving the health of populations and reducing 
the per capita cost of care. It will increase revenues and 
innovation in industry, help governments to fight chronic 
diseases while controlling the budget, and allow media 
to educate and lock­in customers. 
This business model can sustain its effectiveness over 
a long period by fending off the threats of imitation, as 
it is difficult to replicate the established telemonitoring 
center in a jurisdiction, and holdup, as customers can­
not exercise their bargaining power due to the inter­
play of stakeholders. In addition, it helps to avoid slack, 
as organizational complacency is not to be expected, 
and substitution, as new products can reduce the cus­
tomer’s perceived value of this service, but the stake­
holders themselves can and should come up with new 
services (Casadesus­Masanell and Ricart, 2011).
Our analysis is not without flaws or potential bias. 
We assessed theoretical strengths, the potential 
usefulness and the success of extending the B2B model 
in telemonitoring of chronic diseases. We based our 
analysis on the convenience sample of published arti­
cles (Given, 2008). Potential weaknesses of the B2C 
model still remain to be identified. As we are not aware 
of similar studies or business models, convergence 
va lidation has not been assessed (Reis and Judd, 2000).
Future research should provide an in­depth assess­
ment of the business model described, and a financial 
analysis of a fictitious venture that runs on the model 
presented here. Business modeling, like economic 
evaluation, should indeed be iterative and maximize 
the efficiency of R&D in health technology assessment 
(Sculpher et al., 1997). There needs to be, in a similar 
fashion to early health technology assessment (Ijz­
erman and Steuten, 2011), an “early business model 
assessment”.
The telemonitoring domain is increasingly being 
democratized and the proliferation of health gadgets 
will bring a myriad of new telemonitoring apps and ser­
vices. The (WHO Global Observatory for eHealth, 2011) 
ascertains that “mHealth can revolutionize health out­
comes, providing virtually anyone with a mobile phone 
with medical expertise and knowledge in real­time” 
(p. 17). We recommend that decision makers, industry 
leaders, healthcare professionals, media moguls and 
patients consider new modalities of healthcare delivery 
via technology, at a distance. 
Conclusion
Telemonitoring is nowadays ubiquitous and cheap, 
mainly due to the penetration of mobile devices, but 
the established business models are restricting the 
speed and scale of the adoption of telemonitoring. 
We looked into the evolution of the provider-oriented 
approach (B2B) into a service-oriented approach (B2C). 
The cornerstone of the strategy is the value innovation, 
i.e. the strategic move that creates value for the mar­
ket, while simultaneously reducing or eliminating fea­
tures or services that are less valued by the current or 
future market. The market for the B2B telemonitoring 
consists of hospitals, while in the B2C model it consists 
of patients themselves. 
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In this paper we presented the extended model – B2C 
– for the telemonitoring of chronic heart failure, which 
takes into account the healthcare continuum and sup­
ports patients’ health and well­being at home and on 
the move. This is achieved by taking the telemonito­
ring service out of the hospital setting and into a new 
entity – the telemonitoring center – and by introdu cing 
a fourth pillar to the existing B2B model – distributors 
and/or promotors. Hence, the patient becomes the 
customer of the telemonitoring service and the B2C 
model is born. With this maneuver a difference is to 
be expected in the speed and scale of implementation 
of telemonitoring for chronic/multimorbid patients. 
We believe that the B2C model, in combination with 
B2B, is key to population­wide telemonitoring in the 
21st century.
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